Kestra Advisory Services’s BIOATLA INC BCAB Stock Holding History

Kestra Advisory Services’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-885	Closed	-$7.12K	–	3270
2026 Q1	$7.12K	Buy	+885	New	+$10.4K	﹤0.01%	3109

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Kestra Advisory Services's BCAB Position: Q2 2026 in Review

Kestra Advisory Services sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 885 shares — an estimated $7.12K sold.

Kestra Advisory Services first reported a position in BCAB in Q1 2026 and held it in 1 quarter. The position peaked at $7.12K in Q1 2026. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

Kestra Advisory Services reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
Kestra Advisory Services sold 885 BIOATLA INC shares in Q2 2026, an estimated $7.12K.
Kestra Advisory Services first reported a position in BIOATLA INC in Q1 2026 and held it in 1 quarter.
Kestra Advisory Services's BIOATLA INC position peaked at $7.12K in Q1 2026.
21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.